In the brains of AD patients, the abnormal aggregation and phosphorylation of tau proteins disrupt signaling pathways associated with synaptic plasticity, such as those mediated by the N-methyl-D-aspartate receptor (NMDAR). Here, MAPT is linked to Alzheimer disease.